CSF2 and Miyoshi myopathy: Recent trials of idiotypic vaccination in MM have used Id protein coupled to immunogenic carriers, such as key hole limpet haemocyanin and filamentous phage, in combination with adjuvant cytokines (GM-CSF and IL-12) and Id-pulsed dendritic cells amongst others, and have shown that Id-specific T-cell responses can be generated in approximately 50 % of patients [40, 41].